Results 61 to 70 of about 253 (95)

A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy. [PDF]

Photochem Photobiol, 2017
Qiu H, Kim MM, Penjweini R, Finlay JC, Busch TM, Wang T, Guo W, Cengel KA, Simone CB, Glatstein E, Zhu TC.   +10 more
europepmc   +1 more source

Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo. [PDF]

Oncol Rep, 2016
Gabrysiak M, Wachowska M, Barankiewicz J, Pilch Z, Ratajska A, Skrzypek E, Winiarska M, Domagala A, Rygiel TP, Jozkowicz A, Boon L, Golab J, Firczuk M.   +12 more
europepmc   +1 more source

Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies. [PDF]

MedComm (2020)
Zhao W, Wang L, Zhang M, Liu Z, Wu C, Pan X, Huang Z, Lu C, Quan G.   +8 more
europepmc   +1 more source

Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies. [PDF]

Chem Sci
Wang X, Peng J, Meng C, Feng F.
europepmc   +1 more source

The synthesis of dihematoporphyrin ether and related porphyrin dimers [PDF]

Tetrahedron Letters, 1988
Abstract Dihematoporphyrin ether (DHE) has been synthesised by two separate procedures; these routes also allow the synthesis of ether linked porphyrin dimers containing one or two vinyl groups rather than hydroxyethyl side chains. The latter dimers, but not DHE, have anti-cancer activity.
I.K. Morris, A.D. Ward
exaly   +5 more sources

Complications of Whole Bladder Dihematoporphyrin Ether Photodynamic Therapy [PDF]

Journal of Urology, 1989
Photodynamic therapy with dihematoporphyrin ether was used to treat superficial bladder tumors in 7 patients with a followup of at least 1 year. Each patient received treatment to the whole bladder and those with papillary lesions received additional focal treatment.
James I Harty, Michael T Tseng, T J Wieman   +2 more
exaly   +4 more sources

Transcutaneous Determination of Tissue Dihematoporphyrin Ether Content [PDF]

Archives of Dermatology, 1991
• Photodynamic therapy involves the use of light of appropriate wavelength to excite a photosensitizer resulting in tissue destruction. The photosensitizer dihematoporphyrin ether is selectively retained in tumors allowing for tumor destruction while sparing normal structures. Accessibility of skin tumors makes them well suited for photodynamic therapy.
Angelo Russo
exaly   +3 more sources

On the Preparation of Dihematoporphyrin Ether-Free Hematoporphyrin Derivative [PDF]

Biological Chemistry Hoppe-Seyler, 1988
A dihematoporphyrin ether-free hematoporphyrin derivative has been prepared by a base-catalysed dehydration of hematoporphyrin with sodium hydroxide. The identification was performed by HPLC and mass spectroscopy (FD-MS). The reaction of hematoporphyrin with 1 M sodium hydroxide for 24 h yields more than 90% of the monomeric porphyrins.
H, Häberlein, P, Both, M O, Doss
exaly   +4 more sources

In Vitro Photosensitization of Human Head and Neck Squamous Cancer Cells by Dihematoporphyrin‐Ether [PDF]

Otolaryngology - Head and Neck Surgery, 1988
In vitro experiments were performed to evaluate the direct cytotoxic and photosensitizing effects of dihematoporphyrin‐ether (DHE) on the head and neck squamous cancer cell line, UM‐SCC‐38. Normal fibroblasts, normal cultured keratinocytes, and the UM‐MEL‐1 pigmented malignant melanoma cell line were used as controls.
Thomas Carey
exaly   +4 more sources